An LCA carrier is someone who has one altered copy of a gene linked to Leber congenital amaurosis, a rare inherited condition that causes severe vision loss in infants and young children. Carriers have normal vision and no symptoms. The term matters because if two carriers of the same LCA gene have a child together, that child has a 25% chance of being born with the condition.
How LCA Carrier Status Works
Leber congenital amaurosis follows an autosomal recessive inheritance pattern. That means a child needs to inherit two altered copies of the same gene, one from each parent, to develop the condition. A carrier has only one altered copy paired with one normal copy, and that single working copy is enough to keep the retina functioning normally.
Carriers typically do not show any signs or symptoms of the disease. They see normally, pass standard eye exams, and would have no reason to suspect they carry the gene variant unless they undergo genetic testing or have a child diagnosed with LCA.
The Genes Involved
LCA isn’t caused by a single gene. Researchers have identified at least 29 different genes that can cause the condition, and these are classified into subtypes (LCA1 through LCA19). The most common culprits account for the majority of diagnosed cases:
- CEP290: responsible for roughly 15–26% of cases, making it the single most common cause
- GUCY2D: about 12–13% of cases
- CRB1: about 10–13% of cases
- RPE65: about 8–13% of cases, and the gene targeted by the only FDA-approved gene therapy for an inherited retinal disease
- RDH12 and RPGRIP1: each responsible for roughly 9% of cases
Together, the top four genes account for 70–80% of all known LCA cases. Being a carrier means you have a variant in one of these genes (or one of the rarer ones). Two parents must carry variants in the same gene for their child to be at risk.
How Common Are LCA Carriers?
LCA itself is rare. Inherited retinal diseases as a group affect roughly 1 in 3,000 to 4,000 people, but LCA represents a small fraction of that total. For the RPE65 gene specifically, large genetic database studies have found that about 1 in 408 people carry a disease-causing variant. That translates to a biallelic (two-copy) disease frequency of roughly 1 in 665,000 for RPE65-related vision loss. Carrier rates also vary by ancestry: RPE65 carriers are more common among admixed American and African American populations and least common among Ashkenazi Jewish populations.
Carrier frequencies for the other LCA genes are less precisely mapped in population databases, but the overall rarity of the condition means most carriers will never meet another carrier of the same gene by chance.
What Happens When Two Carriers Have Children
When both parents carry a variant in the same LCA gene, each pregnancy carries these odds:
- 25% chance the child inherits both altered copies and develops LCA
- 50% chance the child inherits one altered copy and becomes a carrier like the parents, with no symptoms
- 25% chance the child inherits no altered copies at all
These probabilities apply independently to each pregnancy. Having one affected child does not change the odds for subsequent pregnancies.
How Carrier Status Is Identified
Most people learn they are LCA carriers in one of two ways: their child is diagnosed with LCA and genetic testing confirms which gene is responsible, or they undergo expanded carrier screening before or during pregnancy planning. Carrier screening panels now routinely test for variants across dozens of inherited conditions, and many include genes associated with inherited retinal diseases.
Because at least 29 genes can cause LCA, identifying the exact gene matters. If one partner is a known carrier, the other partner can be tested for variants in that specific gene. If both are carriers of the same gene, the couple has actionable information for family planning.
Options for Carriers Planning a Family
Carrier couples who want to reduce the chance of having a child with LCA have several reproductive options. Preimplantation genetic testing for monogenic disorders (PGT-M) combined with IVF allows embryos to be screened before transfer, selecting only those that did not inherit two copies of the variant. Research on similar autosomal recessive conditions has found this approach to be cost-effective compared to unassisted conception followed by prenatal diagnostic testing.
Prenatal diagnostic testing during pregnancy is another path. Chorionic villus sampling or amniocentesis can determine whether a developing fetus has inherited both altered gene copies. Genetic counselors can walk carrier couples through the timing, accuracy, and implications of each option based on their specific gene variant and personal circumstances.
For carriers partnered with someone who does not carry a variant in the same gene, the risk of having a child with LCA is essentially zero. Their children may become carriers themselves, but carriers live without any vision effects from the condition.